lactitol has been researched along with Cirrhosis, Liver in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (33.33) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 1 (5.56) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Albillos, A; Basili, S; Campo, LD; Ferreira, CN; Guerrero, A; Han, G; Piscaglia, F; Reiberger, T; Scheiner, B; Téllez, L; Violi, F; Zamora, J | 1 |
Morillas, RM; Planas, R; Sala, M | 1 |
Gluud, LL; Morgan, MY; Vilstrup, H | 1 |
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
Angeloni, S; Attili, AF; Bezzi, M; Efrati, C; Masini, A; Merli, M; Nicolao, F; Riggio, O; Salvatori, FM | 1 |
Hayashi, M; Ito, Y; Okawa, S; Tamai, S; Tarao, K | 1 |
Benetti, G; Maggi, A; Moser, P; Salerno, F; Vitaliani, G | 1 |
Boca, M; Duris, I; Kolibás, E; Kratochvíl'ová, E | 1 |
Amodio, P; Attili, AF; Ceccanti, M; Efrati, C; Masini, A; Merli, M; Riggio, O | 1 |
Caschera, M; Diofebi, M; Merli, M; Piat, C; Pinto, G; Riggio, O | 1 |
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Riggio, O; Tremiterra, S; Ziparo, V | 1 |
Candiani, C; Capocaccia, L; Di Rosa, E; Di Rosa, R; Merli, M; Riggio, O; Romiti, A; Testore, GP; Varriale, M | 1 |
Alonso, M; Morgan, MY; Stanger, LC | 1 |
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Pieche, U; Pinto, G; Riggio, O; Tremiterra, S; Ziparo, V | 1 |
Heredia, D; Orteu, N; Rodés, J; Terés, J | 1 |
Biollaz, J; Chollet, C; Lauterburg, BH; Llull, JB; Metzger, J; Wermeille, M | 1 |
Hawley, KE; Morgan, MY; Stambuk, D | 1 |
Arroyo, V; Caballería, J; Heredia, D; Ravelli, G; Rodés, J | 1 |
4 review(s) available for lactitol and Cirrhosis, Liver
Article | Year |
---|---|
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Topics: Anticoagulants; Hemorrhage; Humans; Hypertension; Liver Cirrhosis; Portal Vein; Thrombosis; Treatment Outcome; Venous Thrombosis | 2023 |
[Prevention of hepatic encephalopathy].
Topics: Anti-Bacterial Agents; Central Nervous System Depressants; Contraindications; Diuretics; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Absorption; Lactulose; Liver Cirrhosis; Liver Transplantation; Meta-Analysis as Topic; Peritonitis; Portasystemic Shunt, Surgical; Postoperative Complications; Recurrence; Rifamycins; Rifaximin; Risk Factors; Sugar Alcohols | 2014 |
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols; Watchful Waiting | 2016 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
10 trial(s) available for lactitol and Cirrhosis, Liver
Article | Year |
---|---|
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.
Topics: Adult; Aged; Cathartics; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Complications; Rifamycins; Rifaximin; Sugar Alcohols; Treatment Failure | 2005 |
Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.
Topics: Aged; Ammonia; Dose-Response Relationship, Drug; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Mental Health; Middle Aged; Psychometrics; Sugar Alcohols; Time Factors; Veins | 1994 |
The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
Topics: Adult; Aged; Feces; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Lipid Metabolism; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1992 |
Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Topics: Adult; Aged; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Sugar Alcohols | 1990 |
Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.
Topics: Animals; Bifidobacterium; Clostridium; Coccidia; Disaccharides; Enterobacteriaceae; Feces; Humans; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Liver Cirrhosis; Sugar Alcohols | 1990 |
Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
Topics: Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Psychological Tests; Random Allocation; Sugar Alcohols | 1989 |
Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt.
Topics: Adolescent; Adult; Amino Acids; Clinical Trials as Topic; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Random Allocation; Recurrence; Sugar Alcohols | 1989 |
Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
Topics: Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Neuropsychological Tests; Recurrence; Sugar Alcohols | 1988 |
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Disaccharides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Random Allocation; Sugar Alcohols | 1987 |
Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1987 |
4 other study(ies) available for lactitol and Cirrhosis, Liver
Article | Year |
---|---|
[Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy].
Topics: Aged; Ammonia; Bacteria; Feces; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1995 |
[Lactilol (Importal, 10g in powder made by ZYMA) in the treatment of portal systemic encephalopathy].
Topics: Adult; Aged; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Powders; Sugar Alcohols | 1996 |
Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
Topics: Administration, Oral; Ammonia; Analysis of Variance; Attention; Bacteria; Cathartics; Cognition; Colon; Disaccharides; Follow-Up Studies; Gastrointestinal Transit; Glutamine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Jejunum; Liver Cirrhosis; Male; Memory; Middle Aged; Psychological Tests; Sugar Alcohols | 1999 |
Lactitol: gastrointestinal absorption and effect on blood lactate in healthy volunteers and patients with cirrhosis.
Topics: Adult; Female; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Lactates; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Stereoisomerism; Sugar Alcohols | 1988 |